Both in vitro and in vivo results demonstrated that this nanotheranostic NPs effectively down-regulated TGF-β expression of tumor cells and dramatically enhanced the efficacy of TMZ mediated chemotherapy. The gene discussed is TGFB1; the disease is neoplasm.